Skip to content
Screener

Fate Therapeutics FATE Q4 2025 Annual earnings

Reported February 26, 2026 · Before market open

Revenue$1.4MBeat by $32.4K
EPS-$0.27In line
Revenue estimate$1.3M
EPS estimate-$0.27

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$1.3M
EPS estimate-$0.27

FAQ

When did Fate Therapeutics report Q4 2025 earnings?
Fate Therapeutics (FATE) reported Q4 2025 earnings on February 26, 2026 before market open.
What were Fate Therapeutics's Q4 2025 revenue and EPS?
Fate Therapeutics reported revenue of $1.4M and eps of $-0.27 for Q4 2025.
Did Fate Therapeutics beat estimates in Q4 2025?
Revenue beat the consensus estimate of $1.3M by $32.4K. EPS beat the consensus estimate of $-0.27 by $0.00.
How did Fate Therapeutics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 26.4% from $1.9M a year earlier and eps grew 12.9% from $-0.31.
Where can I find Fate Therapeutics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-073689) and the 10-K periodic report (0001193125-26-073699) directly on SEC EDGAR. The filing index links above go to sec.gov.